The Role of Multisystem Disease in Composition of Autologous Serum tears and ocular surface symptom improvement

Geerling, 2004, Autologous serum eye drops for ocular surface disorders, Br J Ophthalmol, 88, 1467, 10.1136/bjo.2004.044347 Soni, 2016, Blood-derived topical therapy for ocular surface diseases, Br J Ophthalmol, 100, 22, 10.1136/bjophthalmol-2015-306842 Dogru, 2011, Pharmacotherapy of dry eye, Expet Opin Pharmacother, 12, 325, 10.1517/14656566.2010.518612 Quinto, 2008, Autologous serum for ocular surface diseases, Arq Bras Oftalmol, 71, 47, 10.1590/S0004-27492008000700010 Pan, 2017, Autologous serum eye drops for dry eye, Cochrane Database Syst Rev, 2, CD009327 Kitazawa, 1990, The mechanism of accelerated corneal epithelial healing by human epidermal growth factor, Invest Ophthalmol Vis Sci, 31, 1773 De Paiva, 2011, Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca, PloS One, 6, 10.1371/journal.pone.0029017 Tananuvat, 2001, Controlled study of the use of autologous serum in dry eye patients, Cornea, 20, 802, 10.1097/00003226-200111000-00005 Noble, 2004, Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease, Br J Ophthalmol, 88, 647, 10.1136/bjo.2003.026211 Kojima, 2005, The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study, Am J Ophthalmol, 139, 242, 10.1016/j.ajo.2004.08.040 Noda-Tsuruya, 2006, Autologous serum eye drops for dry eye after LASIK, J Refract Surg, 22, 61, 10.3928/1081-597X-20060101-13 Urzua, 2012, Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome, Curr Eye Res, 37, 684, 10.3109/02713683.2012.674609 Celebi, 2014, The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study, Graefes Arch Clin Exp Ophthalmol, 252, 619, 10.1007/s00417-014-2599-1 Liu, 2015, Effectiveness of autologous serum eye drops combined with punctal plugs for the treatment of Sjögren syndrome-related dry eye, Cornea, 34, 1214, 10.1097/ICO.0000000000000542 Read, 2017, Treatment of refractory filamentary keratitis with autologous serum tears, Eye Contact Lens, 43, e16, 10.1097/ICL.0000000000000217 Poon, 2001, Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies, Br J Ophthalmol, 85, 1188, 10.1136/bjo.85.10.1188 Ali, 2018, Use of autologous serum tears for the treatment of ocular surface disease from patients with systemic autoimmune diseases, Am J Ophthalmol, 189, 65, 10.1016/j.ajo.2018.02.009 Hwang, 2014, Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sjögren syndrome, Cornea, 33, 663, 10.1097/ICO.0000000000000147 Phasukkijwatana, 2011, Stability of epitheliotrophic factors in autologous serum eye drops from chronic Stevens-Johnson syndrome dry eye compared to non-autoimmune dry eye, Curr Eye Res, 36, 775, 10.3109/02713683.2011.587935 Welder, 2011, Limbitis secondary to autologous serum eye drops in a patient with atopic keratoconjunctivitis, Case Rep Ophthalmol Med, 2011, 576521 Azari, 2015, Autologous serum eye drops for the treatment of ocular surface disease, Eye Contact Lens, 41, 133, 10.1097/ICL.0000000000000104 Murata, 2008, Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment, J Allergy Clin Immunol, 122, 992, 10.1016/j.jaci.2008.06.013 Schiffman, 2000, Reliability and validity of the ocular surface disease index, Arch Ophthalmol, 118, 615, 10.1001/archopht.118.5.615 Levy, 2019, A retrospective analysis of characteristic features of responder patients to autologous serum eye drops in routine care, Ocul Surf, 17, 787, 10.1016/j.jtos.2019.05.003 Ma, 2017, Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome, Taiwan J Ophthalmol, 7, 213, 10.4103/tjo.tjo_102_17 Savage, 1972, The primary structure of epidermal growth factor, J Biol Chem, 247, 7612, 10.1016/S0021-9258(19)44569-9 Cohen, 1975, Human epidermal growth factor: isolation and chemical and biological properties, Proc Natl Acad Sci Unit States Am, 72, 1317, 10.1073/pnas.72.4.1317 Jiang, 1993, Epidermal growth factor and transforming growth factor alpha specifically induce the activation-and hyperproliferation-associated keratins 6 and 16, Proc Natl Acad Sci Unit States Am, 90, 6786, 10.1073/pnas.90.14.6786 Wang, 2013, Epidermal growth factor (EGF)-induced corneal epithelial wound healing through nuclear factor κB subtype-regulated CCCTC binding factor (CTCF) activation, J Biol Chem, 288, 24363, 10.1074/jbc.M113.458141 Xiao, 2012, Therapeutic effects of epidermal growth factor on Benzalkonium Chloride–induced dry eye in a mouse model, Invest Ophthalmol Vis Sci, 53, 191, 10.1167/iovs.11-8553 Azuma, 2014, Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sjögren's syndrome, Mod Rheumatol, 24, 626, 10.3109/14397595.2013.850766 Azuma, 2015, Rapid decrease in salivary epidermal growth factor levels in patients with Sjögren's syndrome: a 3-year follow-up study, Mod Rheumatol, 25, 876, 10.3109/14397595.2015.1034941 Cocho, 2016, Biomarkers in ocular chronic graft versus host disease: tear cytokine-and chemokine-based predictive model, Investig Ophthalmol Vis Sci, 57, 746, 10.1167/iovs.15-18615 Shiozawa, 1989, Human epidermal growth factor for the stratification of synovial lining layer and neovascularisation in rheumatoid arthritis, Ann. Rheum. Dis., 48, 820, 10.1136/ard.48.10.820 Farahat, 1993, Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis, Ann. Rheum. Dis., 52, 870, 10.1136/ard.52.12.870 Swanson, 2012, Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis, J Immunol, 188, 3513, 10.4049/jimmunol.1102693 Chen, 2015, Amelioration of experimental arthritis by intra-articular injection of an epidermal growth factor receptor tyrosine kinase inhibitor, Clin Exp Rheumatol, 33, 839 Centola, 2013, Development of a multi-biomarker disease activity test for rheumatoid arthritis, PloS One, 8, 10.1371/journal.pone.0060635